ArticleCancers2022

Early-Stage Lung Adenocarcinoma MDM2 Genomic Amplification Predicts Clinical Outcome and Response to Targeted Therapy.

Abhilasha Sinha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.